Shire plc (the “Company”) (LSE: SHP, NASDAQ: SHPG) hereby notifies the market that an application has been made to the UK Listing Authority and the London Stock Exchange for a total of 33,068,902 ordinary shares of 5p each to trade on the London Stock Exchange and to be admitted to the Official List. These shares are being reserved under a block listing in connection with the Shire plc 2.75% Convertible Bonds due 2014.
When issued, these shares will rank equally with the existing issued ordinary shares of the Company.
For further information please contact:
+1 781 482 0999
+44 1256 894157
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.